Valvular heart disease in a man with Parkinson’s disease

Daniel G. Baseman, Sharon C Reimold, Richard B Dewey

Research output: Chapter in Book/Report/Conference proceedingChapter


CASE PRESENTATION A 62-year-old man was diagnosed with Parkinson’s disease in 1993 and treated with amantadine, benztropine, and carbidopa/levodopa. Three years later, due to adverse effects and inadequate efficacy, amantadine and benztropine were eliminated and pergolide was begun. Within 9 months, the dose of pergolide was adjusted to 1 mg three times daily and he was able to reduce the dose of controlled/release carbidopa-levodopa 50/200 from one to one-half tablet three times a day. Following the addition of pergolide, his left hand resting tremor and rigidity resolved and his left hand bradykinesia improved.

Original languageEnglish (US)
Title of host publicationMovement Disorders
Subtitle of host publication100 Instructive Cases
PublisherCRC Press
Number of pages3
ISBN (Electronic)9780203008454
ISBN (Print)1841845248, 9781841845241
StatePublished - Jan 1 2008

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Valvular heart disease in a man with Parkinson’s disease'. Together they form a unique fingerprint.

Cite this